Where I see patients (3)
My reviews
Selected research
-
Stereotactic MRI Guided Adaptive Radiotherapy: a pooled analysis of a master prospective trial.
Journal of the National Cancer Institute
-
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
European urology
-
Delta radiomics to track radiation response in lung tumors receiving stereotactic magnetic resonance-guided radiotherapy.
Physics and imaging in radiation oncology
Clinical trials
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
The proportion of participants who have not demonstrated radiographic progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 or demonstrated clinical progression-free survival (PFS) at 12 month...
Recruiting
5.0